Inactive Instrument

News NovAccess Global Inc. Other OTC

Equities

XSNX

US67001N1072

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

NovAccess Global : Announces New License to Advance its Immunotherapy Platform	30/04	PU
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	28/02	CI
NovAccess Global Inc. announced that it has received $0.1 million in funding from AJB Capital Investments LLC	27/02	CI
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	09/02	CI
NovAccess Global Announces $10.7 Million Financing	03/01	AQ
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	02/12	NE
NovAccess Global Inc. Appoints Roscoe M. Moore, Jr. to Scientific Advisory Board	10/11	CI
NovAccess Global Inc. announced that it expects to receive $10.68 million in funding from Sumner Capital Pty Ltd.	01/23/01	CI
NovAccess Global Inc. announced that it expects to receive $0.055 million in funding	16/23/16	CI
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	12/23/12	CI
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	28/23/28	AQ
NovAccess Global Inc. Partners with BCN Biosciences to Expand Immunotherapy Platform	27/23/27	CI
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	13/23/13	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	24/23/24	AQ
NovAccess Global Inc. announced that it has received $0.055 million in funding from 1800 Diagonal Lending, LLC	20/23/20	CI
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division	16/23/16	CI
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	13/23/13	AQ
NovAccess Global Inc. Enters into a Letter Agreement with AJB Capital Investments, LLC	13/23/13	CI
NovAccess Global Inc. Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalised Healthcare Therapies	01/23/01	CI
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	16/23/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NovAccess Global Inc. Other OTC

Equities

XSNX

US67001N1072

Summary

Filters